Genetic Testing for Familial Hypercholesterolemia in a Pediatric Group: A Romanian Showcase.
Andreea Teodora ConstantinIoana StreataMirela Silvia CovăcescuAnca Lelia RizaIoana RoșcaCorina DeliaLucia Maria TudorȘtefania DorobanțuAdina DragoșDiana RisteaMihai IoanaIoan GherghinaPublished in: Diagnostics (Basel, Switzerland) (2023)
Familial hypercholesterolemia (FH) is a genetic disease marked by high levels of LDL-cholesterol. This condition has long-term clinical implications, such as cardiovascular events, that are evident during adult life. Here, we report on a single-center cross-sectional showcase study of genetic testing for FH in a Romanian pediatric group. Genetic testing for FH was performed on 20 Romanian pediatric patients, 10 boys and 10 girls, admitted with LDL-cholesterol levels over 130 mg/mL to the National Institute for Mother and Child Health "Alesssandrescu-Rusescu" in 2020. Genetic testing was performed using the Illumina TruSight Cardio panel. We identified pathogenic/likely pathogenic variants that could explain the phenotype in 5/20 cases. The involved genes were LDLR and APOB . Clinical signs that suggest the diagnosis of FH are scarce for the pediatric patient, although it can be diagnosed early during childhood by lipid panel screening. Prevention could prove lifesaving for some of these patients.
Keyphrases
- cardiovascular events
- low density lipoprotein
- cross sectional
- end stage renal disease
- coronary artery disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- genome wide
- childhood cancer
- copy number
- cardiovascular disease
- prognostic factors
- peritoneal dialysis
- gene expression
- type diabetes
- quality improvement
- dna methylation
- young adults
- patient reported outcomes
- transcription factor
- early life
- patient reported
- bioinformatics analysis